CaridianBCT and Terumo Transfusion are becoming Terumo BCT, the world leader in blood component technology. Together, we believe in the potential of blood to do even more for the world than it does today. This belief unites our organization, inspires our innovation and strengthens our collaboration with customers to ultimately benefit the patients we all serve.
As we strive to make even safer, higher-quality transfusions available to more people, we can unlock the potential of blood. We can help our customers bring even more treatment options to patients with advanced blood therapies. And we support researchers in developing cell therapies that may fundamentally improve health care. Terumo BCT is guided by our customers' needs, aspirations and ongoing drive to improve efficiency and patient outcomes.
Unlocking the potential of blood